A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy
Clinical trial NCT00266591 · COMPLETED
Trial details
- NCT number
- NCT00266591
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1992-10-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.